nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0407	0.0407	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.038	0.038	CbGpPWpGaD
Brimonidine—ADRA2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0347	0.0347	CbGpPWpGaD
Brimonidine—ADRA2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0337	0.0337	CbGpPWpGaD
Brimonidine—ADRA2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0324	0.0324	CbGpPWpGaD
Brimonidine—ADRA2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0314	0.0314	CbGpPWpGaD
Brimonidine—ADRA2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0314	0.0314	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0309	0.0309	CbGpPWpGaD
Brimonidine—ADRA2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0293	0.0293	CbGpPWpGaD
Brimonidine—ADRA2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0291	0.0291	CbGpPWpGaD
Brimonidine—ADRA2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0283	0.0283	CbGpPWpGaD
Brimonidine—ADRA2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0272	0.0272	CbGpPWpGaD
Brimonidine—ADRA2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0264	0.0264	CbGpPWpGaD
Brimonidine—ADRA2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0264	0.0264	CbGpPWpGaD
Brimonidine—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0263	0.0263	CbGpPWpGaD
Brimonidine—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0255	0.0255	CbGpPWpGaD
Brimonidine—ADRA2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0246	0.0246	CbGpPWpGaD
Brimonidine—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0238	0.0238	CbGpPWpGaD
Brimonidine—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0221	0.0221	CbGpPWpGaD
Brimonidine—ADRA2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.022	0.022	CbGpPWpGaD
Brimonidine—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0215	0.0215	CbGpPWpGaD
Brimonidine—ADRA2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0205	0.0205	CbGpPWpGaD
Brimonidine—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.02	0.02	CbGpPWpGaD
Brimonidine—ADRA2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0185	0.0185	CbGpPWpGaD
Brimonidine—ADRA2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0172	0.0172	CbGpPWpGaD
Brimonidine—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0167	0.0167	CbGpPWpGaD
Brimonidine—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.014	0.014	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00897	0.00897	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00721	0.00721	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.007	0.007	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00674	0.00674	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00669	0.00669	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00654	0.00654	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00652	0.00652	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0065	0.0065	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00625	0.00625	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00609	0.00609	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00607	0.00607	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00605	0.00605	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00573	0.00573	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00565	0.00565	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00557	0.00557	CbGpPWpGaD
Brimonidine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00547	0.00547	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00536	0.00536	CbGpPWpGaD
Brimonidine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00531	0.00531	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0052	0.0052	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00519	0.00519	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00508	0.00508	CbGpPWpGaD
Brimonidine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00495	0.00495	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00493	0.00493	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00484	0.00484	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00459	0.00459	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00437	0.00437	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00435	0.00435	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00424	0.00424	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00424	0.00424	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00422	0.00422	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00408	0.00408	CbGpPWpGaD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00396	0.00396	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00396	0.00396	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00395	0.00395	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00393	0.00393	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.00391	0.00391	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00369	0.00369	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00363	0.00363	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00339	0.00339	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00331	0.00331	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00322	0.00322	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00322	0.00322	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00318	0.00318	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.003	0.003	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00277	0.00277	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00276	0.00276	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00258	0.00258	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00247	0.00247	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0024	0.0024	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0023	0.0023	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00224	0.00224	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00224	0.00224	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00223	0.00223	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00218	0.00218	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0021	0.0021	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00209	0.00209	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00208	0.00208	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00203	0.00203	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00203	0.00203	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00189	0.00189	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00182	0.00182	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0017	0.0017	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00169	0.00169	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00165	0.00165	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00156	0.00156	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00154	0.00154	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00146	0.00146	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00142	0.00142	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00133	0.00133	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00132	0.00132	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00128	0.00128	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00124	0.00124	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0012	0.0012	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.0012	0.0012	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00112	0.00112	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00108	0.00108	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.001	0.001	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000975	0.000975	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000908	0.000908	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000838	0.000838	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000783	0.000783	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000636	0.000636	CbGpPWpGaD
